Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jan 22, 2008
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval for its COGNIS™ cardiac resynchronization therapy defibrillator...
-
Jan 7, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that the Court of Appeals for the Federal Circuit affirmed a District Court ruling which...
-
Jan 7, 2008
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of its Cardiac Surgery and Vascular Surgery businesses to...
-
Jan 4, 2008Company retains ownership of Pain Management business
Boston Scientific Corporation (NYSE: BSX) today announced that it has completed the sale of the controlling interests in its auditory business and...
-
Jan 3, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the upcoming JP Morgan Health Care Conference, in San Francisco. Paul...
-
Dec 28, 2007
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval for its LIVIAN™ cardiac resynchronization therapy defibrillator...
-
Dec 21, 2007TAXUS Liberte has more CE Mark-approved indications than any other drug-eluting stent
Boston Scientific Corporation (NYSE: BSX) announced today that its TAXUS® Liberte™ paclitaxel-eluting coronary stent system has received...
-
Dec 13, 2007
Boston Scientific Corporation (NYSE: BSX) and Avista Capital Partners, a leading private equity firm, today jointly announced the...
-
Nov 29, 2007
Boston Scientific Corporation (NYSE: BSX) today welcomed the recommendation of a U.S. Food and Drug Administration (FDA) advisory panel to approve...
-
Nov 28, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the BMO Capital Markets Healthcare Conference, which is being held...
-
Nov 21, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, which is being held November 27...
-
Nov 19, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that an amended agreement has been reached to settle claims associated with a series of...
-
Nov 6, 2007
Boston Scientific Corporation (NYSE: BSX) and GE Healthcare (NYSE: GE) today announced the industry's first patient data...
-
Nov 5, 2007
Boston Scientific Corporation (NYSE: BSX) today announced the signing of a definitive agreement for the sale of its Cardiac Surgery and Vascular...
-
Oct 31, 2007
Boston Scientific Corporation (NYSE: BSX) announced today that a jury in U.S. District Court in San Francisco has found that Boston Scientific...
-
Oct 26, 2007Dr. Keith Dawkins and Dr. Takahiro Uchida to join the Company
Boston Scientific today announced that Keith Dawkins, M.D., and Takahiro Uchida, M.D., will be joining the Company's Clinical Sciences...
-
Oct 23, 2007
Boston Scientific Corporation (NYSE: BSX) today announced positive three-year results from its CABERNET and BEACH carotid artery...
-
Oct 22, 2007TAXUS IV study demonstrates long-term safety and efficacy of TAXUS drug- eluting stent compared to bare-metal stent
Boston Scientific Corporation (NYSE: BSX) today announced five-year and final follow- up data from its TAXUS IV clinical trial. The...
-
Oct 22, 2007TAXUS ATLAS studies also reinforce deliverability of TAXUS® Liberte® drug-eluting stent in long lesions and small vessels
Boston Scientific Corporation (NYSE: BSX) today announced nine-month data from the pivotal TAXUS ATLAS Small Vessel and Long Lesion...
-
Oct 22, 2007
Boston Scientific Corporation (NYSE: BSX) today welcomed results from the SPIRIT III Clinical Trial, which continue to support the...
-
Oct 21, 2007
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of nearly 7,000 patients from its TAXUS ARRIVE 1...
-
Oct 19, 2007
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2007, as well as guidance for...
-
Oct 17, 2007Approximately 2,300 positions to be eliminated worldwide
Boston Scientific Corporation (NYSE: BSX) today announced several new initiatives designed to enhance short- and long-term shareholder value,...
-
Oct 16, 2007
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Cardiovascular...
-
Oct 9, 2007
Boston Scientific Corporation (NYSE: BSX) today announced CE Mark approval of its CONFIENT™ implantable cardioverter defibrillator (ICD). This...
-
Oct 1, 2007
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30,...
-
Sep 14, 2007
Boston Scientific Corporation (NYSE: BSX) today released data reflecting experience from the first 15,000 patients(1) monitored wirelessly on the...
-
Sep 6, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that the Company's Board of Directors has elected Ray Elliott as a Director. Mr. Elliott,...
-
Sep 5, 2007
Boston Scientific Corporation (NYSE: BSX) today announced results from the TAXUS WOMAN study, a gender specific analysis of the...
-
Sep 4, 2007TAXUS® Stent shows no additional very late stent thrombosis
Boston Scientific Corporation (NYSE: BSX) today announced five-year and final results from its TAXUS II clinical trial,...
-
Sep 2, 2007OLYMPIA Launch Phase Results Show Positive Outcomes in Diabetic Patients
Boston Scientific Corporation (NYSE: BSX) today announced one-year results from the European and Intercontinental launch phases...
-
Aug 30, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that three of its subsidiaries, Guidant Corporation, Cardiac Pacemakers Inc. and Guidant...
-
Aug 29, 2007
Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the European...
-
Aug 28, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bear Stearns 20th Annual Healthcare Conference, which is being held...
-
Aug 23, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that it has successfully amended its $2 billion revolving line of credit and $5 billion...
-
Aug 16, 2007Transaction Would Advance Company's Plan to Divest Non-Strategic Assets and Strengthen Operating and Financial Performance
Boston Scientific Corporation (NYSE: BSX) today announced its intention to explore the sale of its Cardiac Surgery and Vascular Surgery businesses...
-
Aug 9, 2007BSC to assume sole control of Pain Management business and emerging indications program, Advanced Bionics principals to purchase Auditory business and drug pump program
Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an agreement to amend its merger agreement with Advanced Bionics,...
-
Aug 2, 2007Endosurgery group to remain wholly owned by Boston Scientific
Boston Scientific Corporation (NYSE: BSX) today provided an update on its plans to strengthen operating and financial performance as part of its...
-
Jul 24, 2007
Boston Scientific Corporation (NYSE: BSX) today announced its intention to explore the sale of its fluid management business as part of the...
-
Jul 20, 2007
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the second quarter ended June 30, 2007, as well as guidance for net...
-
Jul 19, 2007TAXUS PERSEUS clinical program to evaluate platinum enhanced drug-eluting stent
Boston Scientific Corporation (NYSE: BSX) today announced the beginning of clinical trial enrollment in studies evaluating its third-generation...
-
Jul 17, 2007
Boston Scientific Corporation (NYSE: BSX) today announced the successful implantation of the Company's TAXUS® Petal™ Bifurcation...
-
Jul 13, 2007
Boston Scientific Corporation (NYSE: BSX) today announced that an agreement has been reached to settle claims associated with a series of product...
-
Jul 10, 2007
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the second quarter ended June 30, 2007...
-
Jul 2, 2007Hardware and software innovations offer new benefits to physicians and patients
Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Precision Plus™ Spinal Cord Stimulation (SCS) System, the world's...
-
Jun 25, 2007
Boston Scientific Corporation (NYSE: BSX) today announced it has signed a definitive agreement to acquire Remon Medical Technologies Inc., a...
-
Jun 21, 2007Deal Follows Successful Four-Year Exclusive Distribution of Prolieve® Thermodilatation System
Boston Scientific Corporation (NYSE: BSX) today announced that it has purchased technology for treating symptomatic benign prostatic hyperplasia...
-
Jun 8, 2007
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in Goldman Sachs' 28th Annual Healthcare Conference, which is being held June...
-
Jun 4, 2007
Boston Scientific Corporation (NYSE: BSX) today welcomed the publication of an article in the Journal of American College of Cardiology (JACC)...
-
May 31, 2007Study seeks to confirm the safety and efficacy of systems in routine clinical practice
Boston Scientific Corporation (NYSE: BSX) today announced enrollment of the first patient in the SONOMA post-market approval study of the Company's...